These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Demonstration of in vitro lymphocyte-mediated cytotoxicity against measles virus in SSPE. Kreth WH, Käckell MY, ter Meulen V. J Immunol; 1975 Mar; 114(3):1042-6. PubMed ID: 1089723 [Abstract] [Full Text] [Related]
4. [Interpretation of the results of identification of measles virus antibodies in the serum and cerebrospinal fluid from patients with suspected subacute sclerosing panencephalitis (SSPE)]. Gut W, Panfist A. Med Dosw Mikrobiol; 1991 Mar; 43(3-4):145-52. PubMed ID: 1823377 [Abstract] [Full Text] [Related]
5. Immunologic injury in measles virus infection. III. Presence and characterization of human cytotoxic lymphocytes. Perrin LH, Tishon A, Oldstone MB. J Immunol; 1977 Jan; 118(1):282-90. PubMed ID: 830751 [Abstract] [Full Text] [Related]
7. [Studies on the interaction between cells infected with measles virus and anti-measles antibody. I. Cytotoxic antibody activity of sera obtained from patients with natural measles and subacute sclerosing panencephalitis by use of chronically infected cell lines]. Kuwajima S. Hokkaido Igaku Zasshi; 1986 Jan; 61(1):5-14. PubMed ID: 3699682 [Abstract] [Full Text] [Related]
8. Cell-mediated cytotoxicity against measles virus in SSPE. II. Analysis of cytotoxic effector cells. Kreth HW, Wiegand G. J Immunol; 1977 Jan; 118(1):296-301. PubMed ID: 830753 [Abstract] [Full Text] [Related]
9. Immune response in subacute sclerosing panencephalitis: reduced antibody response to the matrix protein of measles virus. Wechsler SL, Weiner HL, Fields BN. J Immunol; 1979 Aug; 123(2):884-9. PubMed ID: 458157 [Abstract] [Full Text] [Related]
10. Virological and immunological studies in experimental SSPE. Johnson KP, Byington DP, Gaddis L. Neurol Neurocir Psiquiatr; 1977 Aug; 18(2-3 Suppl):495-507. PubMed ID: 616550 [Abstract] [Full Text] [Related]
14. Radioimmunoassay of measles virus antibodies in SSPE. Jankowski MA, Gut W, Kańtoch M. Acta Virol; 1982 Dec; 26(6):481-7. PubMed ID: 6132542 [Abstract] [Full Text] [Related]
15. Measles-specific IgG in CSF and serum from patients with subacute sclerosing panencephalitis. Mehta PD, Patrick BA, Thormar H. Immunology; 1982 Jun; 46(2):423-8. PubMed ID: 7084997 [Abstract] [Full Text] [Related]
17. Subacute sclerosing panencephalitis and multiple sclerosis: in vitro measles immunity and sensitization to myelin basic protein. Sheremata W, Sazant A, Watters G. Can Med Assoc J; 1978 Mar 04; 118(5):509-13. PubMed ID: 343902 [Abstract] [Full Text] [Related]
18. Slow measles encephalitis or subacute sclerosing panencephalitis. Bosnjak I, Barac V. Neurol Croat; 1991 Mar 04; 40(3):187-92. PubMed ID: 1932443 [Abstract] [Full Text] [Related]
19. [Changes in the level of humoral response for measles virus in patients with subacute sclerotic panencephalitis during 1984-1989]. Gut W. Med Dosw Mikrobiol; 1992 Mar 04; 44(3-4):173-85. PubMed ID: 1305922 [Abstract] [Full Text] [Related]